Products & ServicesEvent: September 2, 2026
DIA launched a new course with Swissmedic covering understanding ICH E6(R3) Annex 2 for evolving clinical trial designs.
Published
Signal category
Products & Services
Quote
“NEW COURSE with Swissmedic: Understanding ICH E6(R3) Annex 2 for Evolving Clinical Trial Designs”
— DIA team
Company
DIA
Driving collaboration in drug, device, and diagnostics development in pursuit of a healthier world
- Industry
- Pharmaceutical Manufacturing
- Location
- Washington, US
- Company size
- 561 employees
DIA is the leading global life science membership association driving collaboration in drug, device, and diagnostics development in pursuit of a healthier world. Founded in 1964 with headquarters in Washington, D.C., and offices in Europe and Asia, DIA provides unparalleled networking opportunities, educational resources, scientific research publications, and professional development programs to members in more than 80 countries.
Founded 1964